Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of novel prognostic biomarkers for thyroid cancer by integrated transcriptome analysis of metastasis-associated genes

ABSTRACT: Identification of novel prognostic biomarkers for thyroid cancer by integrated transcriptome analysis of metastasis-associated genes

PROVIDER: PRJNA1198026 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31709150.fastq.gz	Fastqsanger.gz
	SRR31709151.fastq.gz	Fastqsanger.gz
	SRR31709152.fastq.gz	Fastqsanger.gz
	SRR31709153.fastq.gz	Fastqsanger.gz
	SRR31709154.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Identification of novel prognostic biomarkers for thyroid cancer by integrated transcriptome analysis of metastasis-associated genes

Project description:Distant metastasis (DM) is the most important prognostic factor affecting overall survival (OS) of thyroid cancer. The current study aimed to discover prognostic biomarkers to predict thyroid cancer survival, particularly PTC, the most common subtype of thyroid cancer. Four RNA-seq datasets of experimental lung metastasis from 4 transgenic mouse models of PTC, follicular thyroid cancer (FTC), poorly-differentiated thyroid cancer (PDTC), and anaplastic thyroid cancer (ATC) were integrated to screen for candidate genes involved in DM. TCGA-THCA dataset were used to validate the candidate genes. A total of 105 up-regulated and 25 down-regulated differentially expressed genes (DEGs) were identified to be present in all 4 datasets. Regulation of cytokine production, inflammation, immune checkpoint regulation, MAPK/ERK cascade were major enriched pathways in metastatic tumor cells. We identified 7 genes whose overexpression was present in 63 of 498 PTC samples (13%) and was associated with poor OS (p<0.01). Clinically, the 7–gene expression signature was associated with older age at the diagnosis, late stage of tumor, tall-cell variant, and higher aneuploidy and hypoxia score. Mutation load was increased in samples with 7–gene expression signature: 26 samples had more than one driver mutations (47%, 26/55). Deep deletions in other chromosomal locus were frequently found in samples with BRAFV600E point mutations. In contrast, only 7% samples without the 7-gene expression signature had more than one driver mutations (24/243). Increased copy number variants (CNVs) were also observed in metastatic as compared to primary tumor cells such as large deletions and duplications. We conclude that the 7–gene expression signature is associated with poor prognosis and chromosomal instability. It may be a useful biomarker for risk stratification for DM and help decision-making in initial surgical recommendations.

2024-12-19 | GSE284225 | GEO

PRECISE: A prognostic thyroid follicular-cell derived gene signature for papillary thyroid carcinoma

Project description:Papillary thyroid carcinoma (PTC) exhibits heterogeneous behavior. There is a need for effective biomarkers and improved risk stratification methods in PTC. Gene signatures derived from bulk RNA sequencing capture composite transcriptional profiles that are confounded by tumor microenvironment cells. We developed a thyroid follicular cell–enriched gene signature, Prognostic RNA Expression Cell-specific Integrated SignaturE (PRECISE), using single-cell RNA sequencing techniques and evaluated its prognostic utility across three independent cohorts with bulk RNA-seq data and survival outcomes.

2026-02-18 | GSE310793 | GEO

Novel prognostic biomarkers in central neurocytoma

Project description:Novel prognostic biomarkers in central neurocytoma

| PRJNA1216957 | ENA

Prognostic biomarkers of antipsychotic-induced weight gain

Project description:Prognostic biomarkers of antipsychotic-induced weight gain

| PRJNA661304 | ENA

mRNA expression profiles in non-aggressive, invasive and metastatic papillary thyroid cancer

Project description:Paillary thyroid cancer (PTC) is the most common type of thyroid malignancy. Extrathyroidal invasion (ETİ), lymph node metastasis, and distance organ metastasis is poor prognostic factor in PTC. The metastasis is still a leading cause of papillary thyroid cancer death. The early detection of metastatic signature is crucial for identification of thyroid cancer prognosis and personalized therapeutic strategies. In the present study, we present thyroid cancer metastasis and invasivenes related miRNAs identified by comprehensive miRNA expression profiling of formalin-fixed paraffin embedded (FFPE) thyroid tissues obtained from patients belonging to intrathyroidal, invasive and metastatic thyroid carcinoma groups

2020-03-23 | GSE129879 | GEO

miRNA expression profiles in non-aggressive, invasive and metastatic papillary thyroid cancer

2020-03-23 | GSE129878 | GEO

Prognostic classifier based on genome-wide DNA methylation profiling in well differentiated thyroid tumors

Project description:Methylome analysis of different histological thyroid lesions and clinical features, aiming to better understand the DNA methylation deregulation of TC and to identify a prognostic epigenetic signature in well differentiated thyroid carcinomas.

2017-10-20 | GSE97466 | GEO

PRECISE: A prognostic thyroid follicular-cell derived gene signature for papillary thyroid carcinoma

Project description:PRECISE: A prognostic thyroid follicular-cell derived gene signature for papillary thyroid carcinoma

| PRJNA1367083 | ENA

The Discovery and Validation of AML Prognostic Biomarkers

Project description:The Discovery and Validation of AML Prognostic Biomarkers

| PRJNA805341 | ENA

The Discovery and Validation of AML Prognostic Biomarkers

Project description:The Discovery and Validation of AML Prognostic Biomarkers

| PRJNA805342 | ENA